参考文献/References:
[1] Mekhmandarov S,Sandbank J,Cohen M, et al. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions[J].J Nucl Med,1998,39(1):86-91.
[2] Melloul M,Paz A,Ohana G, et al. Double-phase 99Tc-sestamibi scintimmography and trans-scan in diagnosing breast cancer[J].J Nucl Med,1999,140(3):376-380.
[3] Becherer A,Heibich T,Staudenherz A, et al. The diagnostic value of planar and SPECT scintimammography in different age groups[J].Nucl Med Commun,1997,18:710-718.
[4] Maublant J,de Latour M,Mestas D, et al. Technetium-99msestamibi uptake in breast tumor and associated lymph nodes[J].J Nucl Med,1996,37:922-925.
[5] Cordobes MD,Starzec A,Delmon-Moingeon L, et al. Technetium-99m-ses tamibi uptake by human benign and malignant breast tumor cells:Correlation with mdr gene expression[J].J Nucl Med,1996,37:286-289.
[6] Yoon JH,Bom HS,Song HC, et al. Double-phase Tc-99m sestamibi scintimammography to assess angiogenesis and Pglycoprotein expression in patients with untreated breast cancer[J].Clin Nucl Med,1999,24(5):314-318.
[7] Kao CH,Tsai SC,Liu TG, et al. P-glycoprotein and multidrug resistance-related protein expressions in relation to technetium 99m MIBI scintimammography findings[J].Cancer Res,2001,15(61):1412-1414.
[8] Mansi L,Rambaldi PF,Procaccini E, et al. Scintimammography with 99Tcm-tetrofosmin in the diagnosis of breast cancer and lymph node metastases[J].Eur J Nucl Med,1996,23:932-939.
[9] Akcay MN,Akin Y,Karabag B, et al. 9Tcm-tetrofosmin in breast carcinoma and axillary lymph node metastases:a comparative study with 99Tcm-MIBI[J].Clin Nucl Med,1997,22:832-834.
[10] Rodrigues M,Chehne F,Kalinowska W, et al. Uptake of 9Tcm-MIBI and 99Tcm-tetrofosmin into malignant versus nonmalignant breast cell lines[J].J Nucl Med,2000,41:1495-1499.
[11] AMANO S,Inoue T,Tomiyoshi K, et al. In vivo comparison of PET and SPECT radiopharmaceuticals in detecting breast cancer[J].J Nucl Med,1998.1424-1427.
[12] Palmedo H,Bender H,Grüwald F, et al. Comparison of 18F-FDG PET and 99Tcm-MIBI scintimammography in the detection of breast tumours[J].Eur J Nucl Med,1997,24:1138-1145.
[13] Inbriaco M,Vecchio SD,Riccardi A, et al. Scintimammography with 99Tcm-MIBI versus dynamic MRI for non-invasive characterization of breast masses[J].Eur J Nucl Med,2001,28:56-63.
[14] Taillefer R. The role of 99mTc-sestamibi and other conventional radio-pharmaceuticals in breast cancer diagnosis[J].Semin Nucl Med,1999,29:22-23.
[15] Khalkhali I,Cutrone J,Mena I, et al. Technetium-99m-sestamibi scintimammography of breast lesions:Clin and pathological follow-up[J].J Nucl Med,1995,36:1784-1789.
[16] Buscombe JR,Cwikla JB,Holloway B, et al. Prediction of the usefulness of combined mammography and scintimammography in suspected primary breast cancer using ROC curves[J].J Nucl Med,2001,42:3-8.
[17] Buffaz PD,Gauchez AS. Can tumour marker assays be a guide in the prescription of bone scan for breast and lung cancers?[J].Eur J Nucl Med,1999,26:8-11.
相似文献/References:
[1]杨波,刘长春,张勇,等.99Tcm-MIBI运动负荷-静息心肌灌注显像对冠心病患者经皮腔内冠状动脉血管成形术的疗效评价[J].国际放射医学核医学杂志,2009,33(1):37.[doi:10.3760/cma.j.issn.1673-4114.2009.01.037]
YANG Bo,LIU Chang-chun,ZHANG Yong,et al.Evaluation of the outcomes of 99Tcm-MIBI stress-rest perfusion imaging in coronary heart disease with percutaneous transluminal coronary angioplasty[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):37.[doi:10.3760/cma.j.issn.1673-4114.2009.01.037]
[2]张一秋,石洪成.99Tcm-甲氧基异丁基异腈SPECT预测肺癌多药耐药及化疗疗效[J].国际放射医学核医学杂志,2008,32(6):329.
ZHANG Yi-qiu,SHI Hong-cheng.Single photon emission computed tomography imaging using 99Tcm-methoxyisobuty-lisonitrile predict the multi-drug resistance and chemotherapy efficacy of lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):329.
[3]黄建敏,曲雁,潘莉萍.恶性骨肿瘤多药耐药的99Tcm-MIBI体层显像研究[J].国际放射医学核医学杂志,2005,29(4):169.
HUANG Jian-min,QU Yan,PAN Li-ping.Research of 99Tcm-MIBI SPECT imaging for assessment of multidrug resistance in Bone tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):169.
[4]黎海涛.PET-CT在乳腺癌诊断中的应用价值[J].国际放射医学核医学杂志,2005,29(5):220.
LI Hai-tao.The application value of PET-CT in the diagnosis of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):220.
[5]贾志云,邓候富.99Tcm-甲氧基异丁基异腈显像在白血病中的应用价值[J].国际放射医学核医学杂志,2005,29(6):252.
JIA Zhi-yun,DENG Hou-fu.The value of 99Tcm-sestamibi scintigraphy in leukemia[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(2):252.
[6]刘志军.99Tcm-MIBI显像在头颈部恶性肿瘤中的应用[J].国际放射医学核医学杂志,2004,28(5):203.
LIU Zhi-jun.The application of 99Tcm-MIBI imaging in head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(2):203.
[7]李倩.钠/碘转运体的临床实用价值[J].国际放射医学核医学杂志,2003,27(2):56.
LI Qian.Clinical value of sodium iodide symporter[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):56.
[8]袁志斌.核医学影像诊断多发性骨髓瘤的临床价值[J].国际放射医学核医学杂志,2003,27(4):162.
YUAN Zhi-bin.The clinical value of radionulide scintigraphy in the assessing of multiple myeloma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):162.
[9]金玉新.双核素心肌SPECT的研究进展[J].国际放射医学核医学杂志,2003,27(4):171.
JIN Yu-xin.The progress of dual-isotope myocardial perfusion SPECT[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):171.
[10]宋进华.乳腺癌的基因治疗与核素靶向治疗[J].国际放射医学核医学杂志,2003,27(6):241.
SONG Jin-hua.Gene therapy and radionuclides targeting therapy in mammary carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(2):241.
[11]章斌.99Tcm-tetrofosmin在乳腺癌及其转移灶显像中的应用[J].国际放射医学核医学杂志,2001,25(1):12.
ZHANG Bin.Application of 99Tcm-tetrofosmin scintigraphy in the diagnosis of breast cancer and metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(2):12.